Can Therapies Target Genetic Mutations Caused by Asbestos?
Treatments targeting specific genetic mutations are an area of active research. For instance, therapies targeting the p53 pathway or exploiting vulnerabilities in cells with BAP1 mutations are being explored. Immunotherapy and targeted therapy are promising approaches for treating asbestos-related cancers.
